Enhancement of ultrasonically-induced hemolysis by perfluorocarbon- based compared to air-based echo-contrast agents

Ultrasound in Medicine and Biology

Volumn 24, Issue 2, 1998, Pages 285-292

  Miller, Douglas L ^a   Gies, Richard A ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

Cavitation; Cell lysis; Contrast agents; Echocardiography; Hemolysis; Sonography; Ultrasound adverse effects

Indexed keywords

BLOOD; CONTRAST MEDIA; CYTOLOGY; FLUOROCARBONS; MEDICAL IMAGING;

CELL LYSIS; HEMOLYSIS; SONOGRAPHY;

ECHOCARDIOGRAPHY;

ALBUNEX; BR 1; ECHO CONTRAST MEDIUM; FLUOROCARBON; FS 069; IMAGENT US; MRX 130; PERFLUOROPENTANE; PERFLUTREN; SHU 508; UNCLASSIFIED DRUG;

AIR; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; HEMOLYSIS; NONHUMAN; PRIORITY JOURNAL; ULTRASOUND;

AIR; ALBUMINS; ANIMALS; CONTRAST MEDIA; DOGS; FLUOROCARBONS; HEMOLYSIS; MICROSPHERES; POLYSACCHARIDES; ULTRASONICS; ULTRASONOGRAPHY;

EID: 0032007137     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-5629(97)00267-6     Document Type: Article

References (30)

1. Bleeker HJ, Shung KK, Barnhart JL. Ultrasonic characterization of Albunex, a new contrast agent. J Acoust Soc Am. 87:1990;1792-1797.
2. ®-supplemented 40% hematocrit human erythrocytes in vitro by 1 MHz pulsed ultrasound acoustic pressure and pulse length dependence . Ultrasound Med Biol. 22:1996a;927-938.
3. Brayman AA, Azadniv M, Makin IRS, Miller MW, Carstensen EL, Child SZ, Raeman CH, Meltzer RS, Everbach EC. Effect of a stabilized microbubble echo contrast agent on hemolysis of human erythrocytes exposed to high intensity pulsed ultrasound. Echocardiography. 12:1995;13-21.
4. ® microbubble suspensions. J Acoust Soc Am. 99:1996b;2403-2408.
5. Brayman AA, Church CC, Miller MW. Re-evaluation of the concept that high cell concentrations "protect" cells in vitro from ultrasonically induced lysis. Ultrasound Med Biol. 22:1996c;497-514.
6. ® a new ultrasound contast agent consisting of air-filled albumin microspheres suspended in a solution of human albumin. Biotechnol Appl Biochem. 19:1994;307-320.
7. Correas J, Kessler D, Worah D, Quay SC. The first phase shift ultrasound contrast agent: EchoGen. Goldberg BB, ed. Ultrasound contrast agents. (London: Martin Dunitz Ltd., 1997:101-120).
8. de Jong N. Improvements in ultrasound contrast agents. IEEE Eng Med Biol. 15:1996;72-82.
9. ® microspheres. Ultrasonics. 31:1993;175-181.
10. Goldberg BB, Liu JB, Forsberg F. Ultrasound contrast agents a review . Ultrasound Med Biol. 20:1994;319-333.
11. Gottlieb S, Ernst A, Meltzer R. Effect of pressure on echocardiographic videodensity from sonicated albumin an in vitro model . J Ultrasound Med. 14:1995;109-116.
12. Hellebust H, Christiansen C, Skotland T. Biochemical characterization of air-filled albumin microspheres. Biotechnol Appl Biochem. 18:1993;227-237.
13. ® and FS069. Goldberg BB. Ultrasound contrast agents. 1997;43-55 Martin Dunitz Ltd, London.
14. ® suspensions at concentrations approaching in vivo doses. J Acoust Soc Am. 101:1997;1155-1161.
15. Mattrey RF, Pelura TJ. Perfluorocarbon-based ultrasound contrast agents. Goldberg BB. Ultrasound contrast agents. 1997;83-99 Martin Dunitz Ltd, London.
16. Miller DL. The influence of hematocrit on hemolysis by ultrasonically activated gas-filled micropores. Ultrasound Med Biol. 14:1988;293-297.
17. Miller DL, Thomas RM. Ultrasound contrast agents nucleate inertial cavitation in vitro. Ultrasound Med Biol. 21:1995;1059-1065.
18. Miller DL, Thomas RM. Contrast agent gas bodies enhance hemolysis induced by lithotripter shockwaves and high-intensity focused ultrasound in whole blood. Ultrasound Med Biol. 22:1996;1089-1095.
19. Miller DL, Gies RA, Chrisler WB. Ultrasonically induced hemolysis at high cell and gas body concentrations in a thin-disc exposure chamber. Ultrasound Med Biol. 23:1997;625-633.
20. Miller MW, Azadniv M, Doida Y, Brayman AA. Effect of a stabilized microbubble contrast agent on CW ultrasound induced red blood cell lysis in vitro. Echocardiography. 12:1995;1-11.
21. Miller MW, Miller DL, Brayman AA. A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound Med Biol. 22:1996;1131-1154.
22. Schlief R, Schurmann R, Balzer T, Zomack M, Niendorf H. Saccharide based contrast agents. Nanda NC, Schlief R. Advances in echo imaging using contrast enhancement. 1993;71-96 Kluwer Academic Publishers, Dordrecht, Netherlands.
23. Schneider M, Arditi M, Barrau M, Brochot J, Broillet A, Bentrone R, Yan F. BR1 a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles . Invest Radiol. 30:1995;451-457.
24. Skyba DM, Camarano G, Goodman NC, Price RJ, Skalak TC, Kaul S. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol. 28:1996;1292-1300.
25. Unger E, Fritz T, McCreery T, Sahn D, Barrette T, Yellowhair D New T. Liposomes as myocardial perfusion ultrasound contrast agents. Goldberg BB. Ultrasound contrast agents. 1997;57-74 Martin Dunitz Ltd, London.
26. Vandenberg BF, Melton HE. Acoustic lability of albumin microspheres. J Am Soc Echocardiog. 7:1994;582-589.
27. Vuille C, Nidorf M, Morrissey RL, Newell JB, Weyman AE, Picard JH. Effect of static pressure on disappearance rate of specific echocardiographic contrast agents. J Am Soc Echocardiog. 7:1994;347-354.
28. Wight PS. Microbubble contrast agents. Adv Admin Radiol. 5:1995;2-5.
29. Williams AR, Delius M, Miller DL, Schwarze W. Investigation of cavitation in flowing media by lithotripter shock waves both in vitro and in vivo. Ultrasound Med Biol. 15:1989;53-60.
30. ®) on ultrasound-induced cell lysis in a rotating tube exposure system. Echocardiography. 8:1991;423-433.